The National Cancer Institute (INCA) points out that more than 62,000 new cases of prostate cancer will be diagnosed in Brazil in 2018, the second being the most common in men, behind only non-melanoma skin cancer. The increase in rates is related to the development of diagnostic tests and especially to the awareness of men looking for more information about the disease and the ways of prevention that are most obvious in campaigns such as November's Blue.
According to Ionaas Louise Pereira, a urologist at the Parana Institute of Parana (PIO), the trend is new cases to emerge over the years as a result of the aging of the male population. "We know that age is the main risk factor for prostate cancer, and we have a recommendation from the Brazilian Urology Society to start screening 50-year-old prostate cancer in men without risk factors and 45 years in those men with a family history of the disease to his father, brothers and sisters, and the black race population also needs to be more attentive, as apriculture is also a risk factor, "the expert quoted.
During the initial phase, the prostate tumor is asymptomatic, i. E. no symptoms. When some signs begin to appear, including bone pain and weight loss, about 95% of tumors are already at an advanced stage, which prevents the chances of cure. For this reason, it is important to maintain routine exams. "We are currently testing for PSA (prostate specific antigen) in addition to the rectal exam. If there is any change, we will continue the investigation." The final diagnosis is made by a prostate biopsy conducted by an ultrasound. of fusion that happens when we give resonance and ultrasound images to drill a suspicious area in the prostate. At an early stage we can talk about treating the disease, but in advanced cases with metastasis we focus on controlling the disease, "says the urologist.
The choice for the best treatment will depend on some aspects, such as the patient's health, the stage of the disease and life expectancy. "In the initial cases, the indication may be surgery, radiotherapy, with or without hormonal therapy and, in some cases, active monitoring, which is a way to monitor patients with very low-risk tumors more closely." In the United States, for example, , makes up approximately 90% of the total number of patients treated with hormonal therapy All men should be aware of the importance of maintaining routine consultation with a urologist, a doctor who will regularly assess the patient, the PSA score curve, Scotto study prostatata.Vsyaka form of prevention should become routine to be followed, "said Jonatas Luiz Perei R.
FIND OUT MORE
Robotic Surgery: Robotic technique has the same effectiveness as a conventional approach. Access to the country is still limited, as there are only 41 robots in Brazil. In Curitiba, robotic surgery is performed by the hospital Erasto Gaertner.
Immunotherapy: is a treatment that uses the body's own body defense system to attack cancer cells. The main purpose of this therapy is to allow the immune system to act more quickly to fight the disease. Studies have shown that 60% of patients will use some type of immunotherapy until 2020. Other studies have linked treatments such as chemotherapy with immunotherapy to potentiate the results.
Genetic testing: The BRAC 1 and BRAC 2 genetic tests are mainly shown in men who have cases of breast and / or ovarian cancer among female relatives and prostate cancer in male relatives observed over several generations. The study is performed after collection blood or saliva using the New Generation Sequence Methodology (NGS). A modern, very sensitive analysis that is able to read all the DNA bases of the BRCA1 and BRCA2 genes in a single test. The whole process, from the collection of the sample to the release of the report, takes about 20 days.
Hormonal treatment: Drugs or surgery are used to regulate the production of androgens (male hormones) that aid the development of prostate cancer in patients.
This is a commercial content posted by Dino and is not Terra's responsibility